Gram-positive rod surveillance for early anthrax detection

Emerging Infectious Diseases

Volumn 11, Issue 9, 2005, Pages 1483-1486

  Begier, Elizabeth M ^a,b   Barrett, Nancy L ^a   Mshar, Patricia A ^a   Johnson, David G ^a   Hadler, James L ^a   Frenette, Kasia ^c   LoBianco, Lisa ^c   Marshall, Katy ^c   Mlynarski, Diana ^c   Nepaul, Ava ^c   Rabatsky Ehr, Terry ^c  

^a CDC   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c MS#11 ^*

Author keywords

[No Author keywords available]

Indexed keywords

AIR MONITORING; ANTHRAX; ARTICLE; BACILLUS; BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; BLOOD CULTURE; CELL MOTILITY; CEREBROSPINAL FLUID CULTURE; CLOSTRIDIUM; CORYNEBACTERIUM; EARLY DIAGNOSIS; EPIDEMIC; FOLLOW UP; GRAM POSITIVE ASPOROGENOUS ROD-SHAPED BACTERIA; GRAM STAINING; HEALTH SURVEY; HEMOLYSIS; HUMAN; INCIDENCE; LABORATORY; LACTOBACILLUS; MENINGITIS; PHYSICIAN; SEPTICEMIA; TELEPHONE; THORAX RADIOGRAPHY; UNITED STATES;

EID: 23944503757     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1109.041013     Document Type: Article

References (15)

1. Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, et al. Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA. 1999;281:1735-45.
2. Jernigan DB, Raghunathan PL, Bell BP, Brechner R, Bresnitz EA, Butler JC, et al. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis. 2002;8:1019-28.
3. Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis. 2001;7:933-44.
4. Griffith KS, Mead P, Armstrong GL, Painter J, Kelley KA, Hoffmaster AR, et al. Bioterrorism-related inhalational anthrax in an elderly woman, Connecticut, 2001. Emerg Infect Dis. 2003;9:681-8.
5. Sosin DM. Syndromic surveillance: the case for skillful investment. Biosecur Bioterror. 2003;1:247-53.
6. Begier EM, Sockwell D, Branch LM, Davies-Cole JO, Jones LH, Edwards L, et al. The National Capitol Region's emergency department syndromic surveillance system: do chief complaint and discharge diagnosis yield different results? Emerg Infect Dis. 2003;9:393-6.
7. Heffernan R, Mostashari F, Das D, Karpati A, Kuldorff M, Weiss D. Syndromic surveillance in public health practice, New York City. Emerg Infect Dis. 2004;10:858-64.
8. Bioterror detectors go high-tech: research focuses on earlier warning. Chicago Tribune. Apr 8, 2004. p. 14.
9. Departments of Homeland Security and of Health and Human Services Bio Watch fact sheet. [cited 16 June 2004]. Available from https://www.bids.tswg. gov/hsarpa/bids.nsf/F32FE3B1449E699D852 56DC70065EB27/$FILE/ BioWatchFactSheetFINAL.pdf_
10. Meehan PJ, Rosenstein NE, Gillen M, Meyer RF, Kiefer MJ, Deitchman S, et al. Responding to detection of aerosolized Bacillus anthracis by autonomous detection systems in the workplace. MMWR Morb Mortal Wkly Rep. 2004;53 (No. RR-7):1-12.
11. Rechner PM, Agger WA, Mruz K, Cogbill TH. Clinical features of clostridial bacteremia: a review from a rural area. Clin Infect Dis. 2001;33:349-53. Epub 2001 Jun 22.
12. Lober B. Gas gangrene and other Clostridium associated disease. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practices of infectious disease. Philadelphia: Churchill Livingstone; 2000. p. 2549-61.
13. Centers for Disease Control and Prevention. Update: allograft-associated bacterial infections-United States, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:207-10.
14. Centers for Disease Control and Prevention. Update: unexplained deaths following knee surgery-Minnesota, 2001. MMWR Morb Mortal Wkly Rep. 2001;50:1080.
15. Centers for Disease Control and Prevention. Update: Clostridium novyi and unexplained illness among injecting-drug users-Scotland, Ireland, and England, April-June 2000. MMWR Morb Mortal Wkly Rep. 2000;49:543.